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energy transduction. The increased hemodynamic burden seen in DM individuals might 
partly explain increased predisposition to ischemia and left ventricular mechanical dys- 
function seen in diabetic individuals. 
1093-44 Significance of ST-Segment Elevation and Chest Pain 
During Exercise Stress Testing for the Assessment of 
Myocardial Viability 
HR SBP LVM Work (mmHg.U MVQ (Sol/ Efficiency 
(min.‘) (mmHg) (gm) gm/min) gmlmin) (%) 
DM 7023 123 24.2 146 -+ 6002 39 6.5 + 0.5’ 20.6 + 1.6 
11 
Sabahat Bokhari Pejman D. Shamek, Kathleen Hickey, Oswaldo J. Rodriguez, Steven 
R. Bergmann, College of Physicians and Surgeons, Columbia University, New York, NY 
Norm 6322 11423.7 146+7 5052 16 4.6 + 0.2 22.7 -f 1.5 
al 
* p< .05 All values are mean + standard error 
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Background: Imaging modalities such as dobutamine-echocardiography, magnetic res- 
onance imaging and PET have been able to predict functional racovely of the dysfunc- 
tional segments in patients with left ventricular (LV) dysfunction undergoing 
revascularization. However, the data on prediction of recovery of global LV function is 
rather limited. 
Right ventricular (RV) function carries prognostic value in patients with heart failure (HF). 
RV metabolism maybe altered in HF but this has not been well studied. The relationship 
of RV to LV metabolism may also have prognostic value in predicting LV post-operative 
recovery of LV function HF. [IEFIFDG PET imaging allows assessmsnt of glucose utili- 
zation in both LV and RV. 
Subjects and methods: RV and LV glucose utilization was assessed in 17 patients 
(60ttO yrs. male/female 14/3) with coronary artery disease and HF (LV ejection frac- 
tion(LVEF) 25+7 %, NYHA Class 2.6el.l) using the dynamic [lEF]FDG PET imaging. In 
each patient, regions of interest were applied to the whole LV myccardium and the RV 
free wall in a representative midventricular shori axis slice. Patlak analysis was applied to 
the dynamic data to determine the rate glucose uptake (Patlak slope). LV function was 
assessed with radionuclide angiography before and at least 3 months after revascular- 
ization. 
Results: Mean rate of FDG uptake (Patlak slope) was 0.0164~0.0071 miti’ for LV and 
0.0043*0.0029 min.’ for RV with subsequent RVRV ratio of 25*13%. Although the mean 
global LVEF was comparable before and after revascularization (26i7 vs. 26*10 %. 
p=ns), the absolute change in LVEF (AVEF) varied from -13% to 16%. The AVEF had 
a negative correlation with RV patlak slope (r = -0.52, p = 0.026). The best correlation 
was found between ALVEF and RV/LV Patlak ratlo: y = -0.41x + 13.1, r = -0.66, 
p=o.o019. 
Conclusions: [I BF]FDG PET allows the assessment of RV glucose utilization relative to 
the LV. This ratlo is inversely related to LV function recowy and is important in predict- 
ing LV function after revascularization in patients with HF. Our findings emphasize the 
role of RV in HF. 
Background: Exercise induced ST-segment elevation in pathologic Q-wave leads has 
been traditionally associated with an aneurysm or peri-Infarct ischemia. The relationship 
between ST-segment elevation and myocardial viability by positron emission tomography 
(PET) has not yet been studied. Wa evaluated post-infarct ST-segment elevation as 
detected by exercise electrocardiography (ECG) and compared results with PET imaging 
for detecting potentially viable myocardium in infracted regions. 
Method: We evaluated 30 patients (24 male, 11 female) with evidence of O-wave on 12- 
lead ECG. All patients underwent exercise treadmill ECG using the standard Bruce Pro- 
tocol and had evidence of a fixed defect on exercise thallium-24 hour redistribution myo- 
cardial perfusion imaging. Subsequent to exercise ECG all patients underwent cardiac 
PET for assessment of myocardial viability. ST- segment elevation was defined as L 
1 mm above baseline in two consecutive leads. 
Results: Out of 30 total patients ranging in age from 42-66 (mean age 61 f 11 yrs) 17 
patients had exercise induced ST-segment elevation in pathologic Q-wave leads and 13 
patients did not. The mean ejection fraction was 31% * 13. Of the 17 patients who had 
demonstrated exercise induced ST- segment elevation, 9 had ST-segment elevation in 
anterior leads, 5 had ST-elevation in inferior leads, and 3 had ST-elevation in both ante- 
rior and inferior leads. All patients had significant viablllty in the regions of ST-segment 
elevation by cardiac PET. Of the 13 patients who did not have exercise induced ST-seg- 
ment elevation only 3 had significant viability by cardiac PET, p < 0.0001. Exercise 
induced ST-segment elevation had a sensitivity of 65% and specificity of 100% as com- 
pared to cardiac PET. 11 out of 30 patients had exercise induced chest pain and 9 of 
them had viability on PET. 19 out of 30 patients did not have chest pain and 11 of them 
had viability on PET (sensitwity 45%. specificity BO%)Concl”sion: Exercw induced 
ST- segment elevation in pathologic Q-wave leads is indicative of viable myocardium in 
that region. Patients who have exercise induced ST-segment elevation or chest pain 
should undergo cardiac PET to confirm myocardial viability. 
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Oxygen Consumption in Resynchronization Therapy: A 
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Background: In patients with severe heart failure. left bundle branch block and resyn- 
chronization therapy (RT). the effect on myocardial oxygen consumption (MVO,)has not 
been clarified. 
Methods 37 patients (I 1 female, age 63+7 y., EF 22.9+6.%. NYHA Ill, QRS 166*20 ms) 
wth severe heart failure (9 x CAD, 26 x DCM) were investigated before and 3 months 
after biventricular PM implantation by dynamic C-l l-acetate PET. In a I-compatiment 
model acetate clearance was determined for 20 myocardial segments. The global clear- 
ance was multiplied by the quotient of the individual rate-pressure product (RPP) and the 
median of RPP at baseline representing an index of pressure-related MVO,. 
Results After RT the normalized acetate clearance significantly decreased in patients 
wth DCM in contrast to a slight increase in those with CAD. RPP increased from 7461 
mmHg/min+l733 before to 6272 mmHg/min+l667 after 3 months. Regional wall analysis 
in DCM and CAD prior to implantation showed a ratio of MVQ between septum and lat- 
eral wall of 0.63 and 0.69. and 3 months later of 1 .O and 1.02. respectively. 
Conclusion: In DCM pts RT leads to a more economic myocardial performance. In CAD 
this effect cannot be shown. Independent of underlying diseases the regional dysbalan- 
ceof oxidative metabolism resulting from asynchronous contraction is corrected. 
Three-dimensional echocardiography is superior to 20 echo for the evaluation of mitral 
valve (MV) structure and function. However, routine transthoracic use of 3D echo is not 
performed due to the cumbersome nature of current platforms, prolonged data acquisi- 
tion and off-line processing time. TO avoid these limitations, we used a new transthoraclc 
3D matrix array probe (Phillips) that allows on-line 3D rendering, to determine whether 
this modality provides additional information to that of 2D in the assessment of MV dis- 
ease. Methods: 50 patients (mitral stenosis pre-post valvuloplasty, n=5; MV repair, n=5; 
MVP/flail, n=3; St. Jude MV prosthesis, n=2; normal MV, n=34) had 2D echo and real- 
time 3D volume imaging from the parasternal and apical windows. Cropping planes were 
used to slice the 30 volume on-line to visualize MV orifice, commissures, MVleaflets, and 
sub-MV apparatus. Results: Real-time transthoracic 3D rendering of the mitral valve 
apparatus resulted in clinically useful images in 42/50 subjects (64%). Compared to 20, 
real-time 3D with the matrix array probe allowed improved 1) en-face planimetry of the 
MV orifice, 2) visualization of the extent of commissural splitting, as well as MV leaflet 
tear not seen by 20, 3) identification of the prolapsing/ flail scallop confirmed by surgical 
inspection.Conclusion: Dynamic 3D visualization of the MV apparatus in real-time with 
the use of the matrix orobe is feasible in the majority of patients. Real-time 3D may play a 
DCM 
CAD 
C-l l-acetate clearance Ilmin) 
before PM after 3 months 
0.062*0.02 0.072*0.02 
0.067+0.02 0.071+0.02 
p-value 
< .3001 
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